---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-032184"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2023-06-29T23:59:59+00:00"
generated_at: "2026-06-13T14:48:24.744016+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE extends forbearance on defaulted notes to Dec 2023; must raise $2.5M by July 15

## Summary
- Forbearance of remedies extended to earlier of an Event of Default or December 31, 2023.
- Non-refundable consent fee of 2% of original principal added, payable at maturity.
- Interest due June 30 and Sept 30, 2023 deferred and compounded at 20.25% per annum, added to principal.
- New covenant: complete equity financing for at least $2.5 million gross proceeds by July 15, 2023.
- Chief Talent Officer Lisa Sundstrom no longer qualifies as an officer under SEC Rule 16a-1(f).

## SEC filing metadata
- accession: 0001140361-23-032184
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2023-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036123032184/0001140361-23-032184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036123032184/ny20009637x1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-032184
- JSON: https://secwatch.observer/filing/0001140361-23-032184.json
- Plain text: https://secwatch.observer/filing/0001140361-23-032184.txt

## Key facts
- Debt Financings
  SANUWAVE Health, Inc. amended credit facility of original principal amount of the notes with NH Expansion Credit Fund Holdings LP at 20.25% per annum.
  - Instrument: credit facility
  - Principal: original principal amount of the notes
  - Counterparty: NH Expansion Credit Fund Holdings LP
  - Rate: 20.25% per annum
  - Event: amendment
  source text: On June 23, 2023, SANUWAVE Health, Inc., a Nevada corporation (the “Company”), entered into a Fourth Amendment to Note and Warrant Purchase and Security Agreement (the “Amendment”), which amends that certain Note and Warrant Purchase and Security Agreement, dated as of August 6, 2020 (as amended, the “NWPSA”), with the noteholder party thereto (the “Holder”) and NH Expansion Credit Fund Holdings LP, as agent (the “Agent”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036123032184/0001140361-23-032184-index.htm
- Executive change
  Lisa Sundstrom changed role as Chief Talent Officer and Secretary at SANUWAVE Health, Inc..
  - Action: no longer satisfies definition of officer
  - Role: Chief Talent Officer and Secretary
  source text: determined that Ms. Sundstrom no longer satisfies the definition of "officer" set forth in Rule 16a-1(f) promulgated under the Securities Exchange Act of 1934
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036123032184/0001140361-23-032184-index.htm
- Material Agreements
  SANUWAVE Health, Inc. amended Fourth Amendment to Note and Warrant Purchase and Security Agreement with the noteholder party thereto (the "Holder") and NH Expansion Credit Fund Holdings LP, as agent (effective 2023-06-23).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: the noteholder party thereto (the "Holder") and NH Expansion Credit Fund Holdings LP, as agent
  - Effective: 2023-06-23
  source text: On June 23, 2023, SANUWAVE Health, Inc., a Nevada corporation (the “Company”), entered into a Fourth Amendment to Note and Warrant Purchase and Security Agreement (the “Amendment”), which amends that certain Note and Warrant Purchase and Security Agreement, dated as of August 6, 2020 (as amended, the “NWPSA”), with the noteholder party thereto (the “Holder”) and NH Expansion Credit Fund Holdings LP, as agent (the “Agent”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036123032184/0001140361-23-032184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.